Literature DB >> 17106615

Successful treatment of azole-resistant chronic mucocutaneous candidosis with caspofungin.

Melany Jayasinghe, Sibylle Schmidt, Birgit Walker, Martin Röcken, Martin Schaller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17106615     DOI： 10.2340/00015555-0165

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   4.437


× No keyword cloud information.
  3 in total

Review 1.  Periodontal and other oral manifestations of immunodeficiency diseases.

Authors:  M E Peacock; R M Arce; C W Cutler
Journal:  Oral Dis       Date:  2016-10-10       Impact factor: 3.511

2.  Positions and numbers of FKS mutations in Candida albicans selectively influence in vitro and in vivo susceptibilities to echinocandin treatment.

Authors:  M Lackner; M Tscherner; M Schaller; K Kuchler; C Mair; B Sartori; F Istel; M C Arendrup; C Lass-Flörl
Journal:  Antimicrob Agents Chemother       Date:  2014-04-14       Impact factor: 5.191

3.  Successful treatment of chronic mucocutaneous candidiasis caused by azole-resistant Candida albicans with posaconazole.

Authors:  Davide Firinu; Orietta Massidda; Maria Maddalena Lorrai; Loredana Serusi; Monica Peralta; Maria Pina Barca; Paolo Serra; Paolo Emilio Manconi
Journal:  Clin Dev Immunol       Date:  2010-12-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.